Loading organizations...
Based in Denver, Colorado, Arrive Health is a healthcare technology company that develops real-time prescription benefit and cost-transparency software integrated directly into hospital electronic health records. The enterprise platform delivers patient-specific clinical, cost, and coverage data to medical providers at the point of care, helping to reduce out-of-pocket expenses and improve medication adherence. Operating on a business-to-business subscription model, the company's software network currently serves more than 300,000 healthcare providers and reaches approximately 150 million patients, impacting over $26 billion in annual healthcare spending. Arrive Health has raised over $31.5 million in Series B venture funding from a coalition of strategic investors and partners that includes UCHealth, UPMC, Providence Ventures, Epic, and Oracle Cerner. Originally known as RxRevu before rebranding in 2022, the company was founded in 2013 by Carm Huntress and Dr. Kevin O'Brien.
Arrive Health has raised $24.0M across 3 funding rounds.
Arrive Health has raised $24.0M in total across 3 funding rounds.
Arrive Health is a healthcare technology company that builds software solutions to deliver real-time, patient-specific cost, coverage, and clinical data directly into electronic health record (EHR) workflows, such as Epic.[1][2][4] It serves providers, care teams, health systems, pharmacy benefit managers (PBMs), payers, and patients by solving the problem of opaque healthcare costs and coverage, which often leads to unaffordable care, delayed treatment, and administrative friction.[1][3][4] Key products include Real-time Pharmacy Benefit Check for instant medication cost visibility during prescribing and SwiftRx for diagnosis-based medication recommendations with cost data.[1][2] The company shows strong growth momentum, earning a spot on the Inc. 5000 list of fastest-growing private companies for the third consecutive year and recently acquiring pharmacy technology from UPMC Enterprises to expand into patient engagement and automation.[4][5]
Arrive Health originated from a personal challenge over a decade ago when co-founder Greg Peterson helped his mother, Lucy, navigate rising medication costs by ensuring her physician had accurate coverage and lower-cost alternatives.[3][5] This experience sparked the idea for RxRevu, the company's original brand, which launched with EHR-embedded tools providing prescribers real-time prior authorizations, patient-specific costs, and formulary-aligned drug options directly from payers and PBMs.[2][3] As RxRevu grew, the team expanded beyond prescriptions to include medical benefits like labs, specialists, and specialty drugs, building a broader data network for comprehensive point-of-care information.[3] The company rebranded to Arrive Health to reflect this evolution and its mission to eliminate workflow friction across the care continuum, with early traction through partnerships with health systems and HITRUST CSF certification for secure implementation.[2][3]
Arrive Health rides the wave of healthcare transparency mandates and real-time data standards like RTPB, fueled by rising drug costs and patient affordability crises that force trade-offs between health and basic needs.[4][6][8] Timing is ideal amid CMS rules pushing EHR vendors toward embedded benefit tools and growing adoption by major systems, positioning Arrive as a key enabler of value-based care.[1][6][8] Market forces like payer-provider collaboration and AI-driven analytics favor its network approach, reducing prior auth delays and enabling data-driven prescribing that cuts waste.[2][3] It influences the ecosystem by partnering with EHR giants, PBMs, and innovators, advocating for unified data sharing to bridge silos and empower providers as affordability catalysts.[4]
Arrive Health is poised to dominate point-of-care transparency with its expanding suite, including recent UPMC acquisitions for pharmacy automation and patient engagement, targeting adherence and access amid escalating barriers.[4][5] Trends like AI-enhanced RTPB, broader medical benefit integration, and regulatory pushes for cost visibility will accelerate growth, potentially capturing more EHR market share.[1][3][8] Its influence may evolve into a full care navigation platform, uniting stakeholders to redefine affordable care—clearing the way, as its origins with Lucy remind us, for providers and patients to prioritize health over hidden costs.[3][5][6]
Arrive Health has raised $24.0M across 3 funding rounds. Most recently, it raised $7.0M Series B in January 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 1, 2021 | $7M Series B | JAZZ Venture Partners | Steve Weinstein | Announced |
| May 1, 2019 | $16M Series A | Richard Zane, MD | JAZZ Venture Partners, Steve Weinstein, Children's Hospital Colorado Center For Innovation, Inception Health, Presbyterian Healthcare Services, UnityPoint Health, University OF Virginia | Announced |
| Aug 14, 2014 | $1M Venture Round | — | Arnold Schaffer, NAT Turner, Vivek Garipalli, Zach Weinberg, Galvanize Climate Solutions | Announced |
Arrive Health has raised $24.0M in total across 3 funding rounds.
Arrive Health's investors include Jazz Venture Partners, Steve Weinstein, Richard Zane, MD, Children's Hospital Colorado Center for Innovation, Inception Health, Presbyterian Healthcare Services, UnityPoint Health, University of Virginia, Arnold Schaffer, Nat Turner, Vivek Garipalli, Zach Weinberg.
